Beam Therapeutics (NASDAQ:BEAM) Releases Quarterly Earnings Results, Beats Estimates By $0.34 EPS

Beam Therapeutics (NASDAQ:BEAM – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($1.08) earnings per share for the quarter, beating the consensus estimate of ($1.42) by $0.34, Briefing.com reports. Beam Therapeutics had a negative return on equity of 42.04% and a negative net margin of 412.45%. The business had revenue […]

Related Keywords

Canada ,United States ,America ,Giuseppe Ciaramella ,America Corp ,Renaissance Technologies ,Citigroup ,Vanguard Group Inc ,Barclays ,Beam Therapeutics Company Profile ,Beam Therapeutics Inc ,Royal Bank ,Norges Bank ,Beam Therapeutics ,Get Free Report ,Street Corp ,Therapeutics Inc ,Beam Therapeutics Daily ,Nasdaq Beam ,Beam ,Medical ,Earnings ,